Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
1,318,495
-
Total 13F shares
-
605,591
-
Share change
-
+243,359
-
Total reported value
-
$10,089,353
-
Price per share
-
$16.58
-
Number of holders
-
24
-
Value change
-
+$4,044,270
-
Number of buys
-
9
-
Number of sells
-
7
Institutional Holders of PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) as of Q3 2024
As of 30 Sep 2024,
PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
605,591 shares.
The largest 10 holders included
BVF INC/IL, ADAR1 Capital Management, LLC, BML Capital Management, LLC, Lynx1 Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, CM Management, LLC, Frazier Life Sciences Management, L.P., BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, and CITADEL ADVISORS LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.